We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Agreement Recitals Sample Clauses

Agreement RecitalsAppropriate Supervisory Authority 1.1 Bankruptcy Exceptions 3.1(c) Benefit Plans 2.3(f) Board of Directors 3.1(f) Business Combination 8.7 business day 1.2 Capitalization Date 3.1(b) Capital Interests 3.1(b) CDCI Recitals CDFI 3.1(d) CDFI Application 2.3(l) CDFI Application Update 2.3(l) CDFI Events 1.1 Certified Entities 4.1(d)(iv) Charter 2.3(d) Closing 2.2 Closing Date 2.2 Code 3.1(n)
Agreement Recitals. Applicable GMP Section 5.2
Agreement Recitals. Allocation 11.1 Alternative Proposal 6.13 Antitrust Authorities 6.3 Assumed Liabilities 2.2 Balance Sheet 5.6 Buyer Indemnitees 12.1 Closing 8.1 Closing Date 8.1 Closing Statement 3.2(a) CPA Firm 3.2(b) Deductible 12.3(c) Divestiture 6.2(a) Employee Employee Agreement Employee Agreement 10.1 Employee Plans 5.13(a) Environmental Permits 5.14(a)(ii) ERISA Affiliate 5.13(a) Estimated Purchase Price 3.1 Final Closing Statement 3.2(b) Final Purchase Price 3.1 Financial Statements 5.6 Former Employee Employee Agreement Indemnified Party 12.5(a) Indemnifying Party 12.5(a) Large Volume Meters 6.8 Leased Assets 6.7 Notice Period 12.5(a) Objection 3.2(b) PBGC 5.13(c) - - Pre-Closing Tax Period 11.5 Proxy Statement 6.1(f)(i) PUHCA 2005 4.10 Purchase Price 3.1 Representatives 6.1(d) Restricted Information 6.1(d) Retained Contract Liabilities 2.2(b)(i) Retained Liabilities 2.3 Review Period 3.2(b) Seller Indemnitees 12.2 Seller Marks 6.4 Seller’s Pension Plans Employee Agreement Seller’s 401(k) Plan Employee Agreement Seller’s Stockholder Approval 7.1(g) Settlement Payment 1.1 Seller's Meeting 6.1(f)(iii) Straddle Period 11.6 Transition Services Agreement 6.6 Transaction Taxes 11.3 Upset Date 9.1(e) WARN Act Employee Agreement
Agreement RecitalsBusiness Day Section 1.1 Certificate of Merger Section 2.1 Certificates Section 2.9 Claim Section 5.7 Closing Section 2.1 Closing Date Section 2.1 Code Section 2.10 Common Shares Section 1.1 Common Share Merger Consideration Section 2.6 Common Share Offer Consideration Section 1.1 Company Recitals Company Articles Section 3.1 Company Balance Sheet Date Section 3.6 Company Board Section 1.3 Company Board Approval Section 3.22 Company Board Recommendation Section 1.3 Company Bylaws Section 3.1 Company Credit Agreement Section 5.1 Company Disclosure Schedule Article 3 Company Expense Reimbursement Payment Section 7.5 Company IT Systems Section 3.27 Company Intellectual Property Section 3.10 Company Material Adverse Effect Section 3.1 Company Permits Section 3.19 Company Plan Section 3.14 Company Registered Intellectual Property Section 3.10 Company Representatives Section 5.4 Company SEC Documents Section 3.7 Company Termination Payment Section 7.5 Confidentiality Agreement Section 5.4 Continuing Directors Section 5.13 Contract Section 3.15 Control Section 8.10 Controlled Group Liability Section 3.14 D&O Insurance Section 5.7 Dissenting Shares Section 2.6 Dissenting Shareholder Section 2.6 Effective Time Section 2.1 Environmental Laws Section 3.20 Environmental Permit Section 3.20 ERISA Section 3.14 ERISA Affiliate Section 3.14 Exchange Act Section 1.1 Exercise Notice Section 5.12 Fully Diluted Basis Section 8.10 Governmental Authority Section 3.5 Hazardous Materials Section 3.20 Indemnified Parties Section 5.7 Intellectual Property Section 3.10 Knowledge Section 8.10 Laws Section 3.9 Losses Section 5.7 Material Contract Section 3.15 Merger Section 2.1 Merger Consideration Section 2.6 Minimum Condition Annex A Multiemployer Plan Section 3.14 Multiple Employer Plan Section 3.14 Notice Date Section 5.12
Agreement Recitals. The discloser is a student of the AGSM @ UNSW Business School and is required to undertake several projects ("the Projects").
Agreement Recitals. Control Section 1.1 Cost Section 6.3 Demonstration Plant Section 2.5(a) Discloser Section 12.1 EPC Contracts Section 2.4 Finder’s Fee Section 3.4(a) first right Section 2.4 Indemnifying Licensee Section 9.2(b) Indemnitee Section 9.4 Indemnitor Section 9.4
Agreement Recitals. Allocations 1.5 Assumed Liabilities 1.2(a) Authorizations 2.11(a) Basket 8.2 / 8.3 Benefit Plans 2.17(a) Business Marks 5.11 Cap Amount 8.2 / 8.3 Cash Portion 1.3(a) Closing 7.1 Closing Date 7.1 Closing Date Balance Sheet 1.4(b)
Agreement Recitals. =CONFIDENTIAL TREATMENT REQUESTED: MATERIAL HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. AVENTIS Recitals BANKRUPTCY CODE Section 3.1 DISPUTE NOTICE Section 9.1 EFFECTIVE DATE Recitals EXCLUDED TARGET Section 2.2 FINAL TARGET REPORT ATTACHMENT A GENERIC RIGHTS Section 3.2 HIT COMPOUND(S) ATTACHMENT A HIT EXPLORATION PROGRAM C.F. PROGRAM INDEMNIFIED PARTY(IES) Section 7.2 INDEMNIFYING PARTY Section 7.2 LICENSED TECHNOLOGY Section 3.1 LOSSES Section 7.2 NEOGENESIS Recitals PHASE II CLINICAL TRIALS Section 4.3 PHASE III CLINICAL TRIALS Section 4.3 PRELIMINARY COMPOUND ATTACHMENT A PRIMARY ACTIVE COMPOUNDS ATTACHMENT A PRIMARY ENDPOINT Section 4.3 PROGRAM TERM Section 8.1 SCREENING PERIOD Section 2.4 SCREENING PROGRAM C.F. PROGRAM and Section 2.4 SELECTED SERIES ATTACHMENT A STEERING COMMITTEE Section 2.7
Agreement Recitals. Archemix Recitals Archemix AME License 2.1.1 Archemix Claims 6.1 Archemix Indemnitees 6.1 Bankruptcy Action 7.2.4 Collaboration Agreement 2.5.2(a) Collaboration/License Negotiation Period 2.5.2(a) Collaboration/License Option 2.5.1 Collaboration/License Option Exercise Notice 2.5.2(a) Collaboration/License Option Period 2.5.2(a) Disclosing Party 1.22 Effective Date Recitals Exclusive Feasibility Study Target 2.3.2 Exclusive Feasibility Study Target Notice 2.3.2 Expired Collaboration/License Option 2.5.3 Feasibility Study License 2.1.1 Feasibility Study Option 2.2.1 Feasibility Study Option Exercise Notice 2.2.2 Feasibility Study Option Period 2.2.2 Feasibility Study Target Notice 2.3.1 Gilead Indemnitee 6.4 Indemnified Party 6.3 Indemnifying Party 6.3 Infringement 4.5.1 Infringement Notice 4.5.1
Agreement Recitals. Claims 9.1 Disclosing Party 1.13 Disputed Matters 10.3.1 ILI Recitals ILI Indemnitees 9.2 Improvement Patent Rights 6.2.1(a) Indemnified Party 9.3 Indemnifying Party 9.3 Informed Consent 3.5 Infringement 6.2.1(a) Infringement Notice 6.2.1(a) Losses 9.1 Marketing Plan 3.2 Oral DNA Recitals Oral DNA Indemnitees 9.1 Party/Parties Recitals Product Payments 4.1.1 PST® Result Reports 3.4 Receiving Party 1.13 Term 7.1 Third Party License 4.1.2 Third Party Product Payment 4.1.2 Withholding Taxes 4.4